Testing effectiveness (Phase 2)UnknownNCT02173223
What this trial is testing
Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt
Who this might be right for
Advanced Glaucoma
New York Glaucoma Research Institute 10